Ambev SA ADR (ABEV)

Ambev SA ADR (ABEV) is a NYSE-listed American depositary receipt tied to Ambev S.A. common stock. This security gives investors indirect exposure to the underlying company rather than direct ownership of shares on its home market. The ADR is classified as a depositary receipt for common stock and is associated with the consumer staples sector and the beverages industry. Ambev’s business is centered on beverage production and distribution, with activity spanning alcoholic and non-alcoholic drink categories. As a listed ADR, ABEV reflects the trading and listing structure of the instrument, not a separate operating business.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-ABEV
$3.94
27.5% Upside
Undervalued
$3.36
8.8% Upside
Fair
Great
June 24, 2026
January 11, 2027
0.0229
0.7%
July 30, 2026
15.7x
2.7x
2.8x
48.109 B
44.302 B
1.2%
26.7%
8.9
88.9%
142.4%
Valuation • Fair Value

Ambev SA ADR (NYSE-ABEV) Fair Value by Valuation Model

Compare the primary fair value estimate for Ambev SA ADR (NYSE-ABEV) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$3.94

Estimated upside of 27.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$4.61

Discounted cash flow valuation reference.

Ben Graham Formula Value

$2.19

Classic Ben Graham valuation formula reference.

DDM Fair Value

$5.37

Dividend discount model valuation reference.

EPV Fair Value

$4.04

Earnings power value estimate.

Comps Fair Value

$3.01

Comparable-company valuation reference.

Analyst Price Target

$3.36

Analysts imply upside of 8.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Ambev SA ADR (NYSE-ABEV) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Ambev SA ADR (NYSE-ABEV)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

17.03 B

Current operating scale indicator.

Revenue Forecast

18.071 B

Forward revenue estimate.

EBITDA

5.215 B

Current operating profitability reference.

EBITDA Forecast

6.134 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Ambev SA ADR (NYSE-ABEV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ambev SA ADR (NYSE-ABEV)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.79

No elevated caution signal from this screen.

Altman Z-Score

8.9

Relatively strong balance-sheet zone.

FCF / Net Income

142.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ambev SA ADR (NYSE-ABEV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ambev SA ADR (NYSE-ABEV)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

January 11, 2027

Ex-Dividend Date

June 24, 2026

Dividend Yield

0.7%

Income yield reference.

Upcoming Dividend

0.0229

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

88.9%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Ambev SA ADR (NYSE-ABEV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Ambev SA ADR (NYSE-ABEV) Stock Forecast & Technical Outlook

Review Ambev SA ADR (NYSE-ABEV) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Ambev SA ADR (NYSE-ABEV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Ambev SA ADR (NYSE-ABEV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Ambev SA ADR (NYSE-ABEV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Ambev SA ADR (NYSE-ABEV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Ambev SA ADR (NYSE-ABEV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Ambev SA ADR (NYSE-ABEV)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Ambev SA ADR (NYSE-ABEV) has a Hold consensus, with 1 buy, 6 hold and 2 sell recommendations in the current data set.

Buy 1
Hold 6
Sell 2
FAQ Fast Investor Answers

Ambev SA ADR (NYSE-ABEV) Stock FAQ

Quick answers about Ambev SA ADR (NYSE-ABEV) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$3.94
Estimated upside 27.5%
Valuation Rating
Undervalued
Estimated upside of 27.5%
Analyst Target
$3.36
Implied upside 8.8%
Financial Health
Great
Current financial-health read

The current fair value estimate for Ambev SA ADR (NYSE-ABEV) is $3.94. This implies an estimated upside of 27.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.5% versus the current market price.

The available analyst price target for Ambev SA ADR (NYSE-ABEV) is $3.36. The analyst target implies estimated upside of 8.8%.

The current financial health read for Ambev SA ADR (NYSE-ABEV) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Ambev SA ADR (NYSE-ABEV) is July 30, 2026.

Based on the current data, dividend yield is 0.7%, upcoming dividend amount is 0.0229, ex-dividend date is June 24, 2026, payment date is January 11, 2027.

The current P/E ratio listed for Ambev SA ADR (NYSE-ABEV) is 15.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Ambev SA ADR is 48.109 B.

The current enterprise value listed for Ambev SA ADR is 44.302 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ambev SA ADR is NYSE-ABEV, and the stock is listed on NYSE.

Ambev SA ADR (NYSE-ABEV) is listed on NYSE.

The current debt-to-total-capital ratio listed for Ambev SA ADR is 1.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ambev SA ADR is 26.7%. Free float helps investors understand how much of the share base is available for public trading.